Enter search term

ZEUS Borrelia MTTT™ to be Featured on Lifetime Network's Access Health Series

Aug 20, 2020

ZEUS Borrelia MTTT™ to be Featured on Lifetime Network's Access Health Series


The word is getting out regarding how ZEUS Borrelia MTTT™ is improving early Lyme Disease diagnosis.  Lifetime network will feature the only FDA cleared Borrelia Modified Two-Tiered Testing (MTTT) algorithm on their Access Health series scheduled to air on September 25th and October 3rd, 2020.

More to come on this exciting news in the coming weeks, but for now, be sure to mark these dates to hear first-hand from Dr. Raymond Dattwyler, M.D. as he discusses how MTTT is helping clinical laboratorians simplify Lyme testing processes and improving detection of early Lyme all while reducing turnaround time thereby helping patients get the treatment they need.

The advantages of implementing ZEUS Borrelia MTTT™ are clear.  The all-ELISA algorithm is the simple, sensitive and specific alternative that is changing the game in Lyme disease testing.



ZEUS Borrelia MTTT™ Advantages

  • Reduces the number of missed clinically positive patient samples, especially in early Lyme (stage 1 and 2)
  • Removes burden of blots and subjectivity of readings
  • Enables simple and flexible first-tier and second-tier testing
  • Improves overall lab workflow and cost efficiencies, eliminating send-outs
  • Improves turnaround time



ZEUS Borrelia MTTT™ is a simpler, more cost effective, faster and better way to more accurately detect Lyme disease than using immunoblots. This updated algorithm detected up to 30% more positive patients in acute early Lyme disease, the critical time to correctly identify and treat!

If you are sending out your confirmatory tests instead of running them in house, you no longer have to!  ZEUS Borrelia MTTT™ makes it easier for all labs to quickly turn around both steps of the Lyme disease testing algorithm.

If you are still running Lyme disease immunoblots in your laboratory, take a look at the clinical data to see how ZEUS Borrelia MTTT™ improves detection in early Lyme disease.

If you need more information please visit zeuslyme.com or contact the ZEUS sales team.

With the only FDA-approved Modified Two-Tiered Testing algorithm available, let us help you improve your ability to provide your physicians the right answers their patients sorely need!



The ZEUS Scientific Team

Back Share